{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:58:45Z","timestamp":1791244725008,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jconrel.2011.08.017","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T00:02:18Z","timestamp":1313884938000},"page":"264-273","source":"Crossref","is-referenced-by-count":640,"title":["Transport of drugs across the blood\u2013brain barrier by nanoparticles"],"prefix":"10.1016","volume":"161","author":[{"given":"Stefanie","family":"Wohlfart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Gelperina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2011.08.017_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1359-6446(01)02082-7","article-title":"Why is the global CNS pharmaceutical market so under-penetrated?","volume":"7","author":"Pardridge","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: the problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1083\/jcb.34.1.207","article-title":"Fine structural localization of a blood\u2013brain barrier to exogenous peroxidase","volume":"34","author":"Reese","year":"1967","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood\u2013brain barrier: development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1023\/A:1012040425146","article-title":"Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway","volume":"14","author":"Pauletti","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0030","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1046\/j.1471-4159.1998.70051781.x","article-title":"CNS drug design based on principles of blood\u2013brain barrier transport","volume":"70","author":"Pardridge","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0035","first-page":"937","article-title":"Pharmacokinetics and blood\u2013brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody","volume":"26","author":"Wu","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.2042-7158.1996.tb07112.x","article-title":"The blood\u2013brain barrier: principles for targeting peptides and drugs to the central nervous system","volume":"48","author":"Begley","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood\u2013brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0050","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.287.5460.1960","article-title":"Drug discovery: a historical perspective","volume":"287","author":"Drews","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Blood\u2013brain barrier drug targeting: the future of brain drug development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol. Interv."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0060","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1172\/JCI109509","article-title":"Osmotic blood\u2013brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery","volume":"64","author":"Neuwelt","year":"1979","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/108729002761381320","article-title":"Trafficking of intracerebroventricularly injected antisense oligonucleotides in the mouse brain","volume":"12","author":"Chauhan","year":"2002","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00701-005-0707-z","article-title":"Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial","volume":"148","author":"Westphal","year":"2006","journal-title":"Acta Neurochir. (Wien)"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/1357-4310(96)88720-X","article-title":"Transporting therapeutics across the blood\u2013brain barrier","volume":"2","author":"Abbott","year":"1996","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0006-8993(70)90123-X","article-title":"Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard","volume":"24","author":"Oldendorf","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery \u2014 possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.102.046532","article-title":"Inhibition of P-glycoprotein by newer antidepressants","volume":"305","author":"Weiss","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0100","series-title":"The Blood\u2013brain Barrier and Drug delivery to the CNS","first-page":"121","article-title":"Specific mechanisms for transporting drugs into brain","author":"Tsuji","year":"2000"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/030089160809400220","article-title":"Use of nanoparticles for cerebral cancer","volume":"94","author":"Kreuter","year":"2008","journal-title":"Tumori"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0110","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijpharm.2005.03.031","article-title":"Colloidal carriers and blood\u2013brain barrier (BBB) translocation: a way to deliver drugs to the brain?","volume":"298","author":"Garcia-Garcia","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1166\/jns.2009.003","article-title":"Colloidal carriers: a promising way to treat central nervous system diseases","volume":"1","author":"Andrieux","year":"2009","journal-title":"J. Nanoneurosci."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0125","first-page":"165","article-title":"Nanoparticles","volume":"10","author":"Kreuter","year":"1994"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2006.06.023","article-title":"PLA\/PLGA nanoparticles for sustained release of docetaxel","volume":"325","author":"Musumeci","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i5.20","article-title":"PLGA nanoparticles in drug delivery: the state of the art","volume":"21","author":"Bala","year":"2004","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijpharm.2008.01.010","article-title":"Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles","volume":"356","author":"Maksimenko","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2008.07.004","article-title":"Freeze drying of human serum albumin (HSA) nanoparticles with different excipients","volume":"363","author":"Anhorn","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejpb.2009.02.002","article-title":"Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage","volume":"72","author":"Holzer","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0155","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0160","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers' entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0939-6411(02)00081-4","article-title":"Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis","volume":"54","author":"Gessner","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ijc.22296","article-title":"Aclarubicin-loaded cationic albumin-conjugated pegylated nanoparticle for glioma chemotherapy in rats","volume":"120","author":"Lu","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(99)00007-3","article-title":"Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain","volume":"59","author":"Yang","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(95)00023-J","article-title":"Passage of peptides through the blood\u2013brain barrier with colloidal polymer particles (nanoparticles)","volume":"674","author":"Kreuter","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0185","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/jps.20357","article-title":"Double-coated poly(butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration","volume":"94","author":"Das","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0190","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.biomaterials.2005.12.021","article-title":"Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery","volume":"27","author":"Kim","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0195","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1023\/A:1018983904537","article-title":"Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles","volume":"16","author":"Gulyaev","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0200","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11095-008-9763-4","article-title":"Design of biodegradable nanoparticles for oral delivery of doxorubicin: In vivo pharmacokinetics and toxicity studies in Rats","volume":"26","author":"Kalaria","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0205","doi-asserted-by":"crossref","first-page":"e23.B","DOI":"10.1208\/aapsj060323","article-title":"Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies","volume":"6","author":"Reddy","year":"2004","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2009.01.011","article-title":"Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model","volume":"1261","author":"Wang","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0215","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/js980084y","article-title":"Nanoparticle technology for delivery of drugs across the blood\u2013brain barrier","volume":"87","author":"Schroeder","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0220","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1012098005098","article-title":"Delivery of loperamide across the blood\u2013brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles","volume":"14","author":"Alyautdin","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0225","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2006.12.012","article-title":"Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain","volume":"118","author":"Kreuter","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.05.022","article-title":"Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123","volume":"122","author":"Tosi","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2005.11.040","article-title":"Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles","volume":"310","author":"Gao","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0939-6411(99)00073-9","article-title":"Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system","volume":"49","author":"Friese","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0245","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/10611860903112842","article-title":"Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles","volume":"17","author":"Kurakhmaeva","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0250","doi-asserted-by":"crossref","first-page":"e14213","DOI":"10.1371\/journal.pone.0014213","article-title":"Nanoparticulate transport of oximes over an in vitro blood\u2013brain barrier model","volume":"5","author":"Wagner","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/nnm.09.67","article-title":"Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution","volume":"5","author":"Bondi","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0260","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2008.01.039","article-title":"Suresh, Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease","volume":"1200","author":"Wilson","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2007.03.012","article-title":"Transport of stavudine, delavirdine, and saquinavir across the blood\u2013brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles","volume":"340","author":"Kuo","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0270","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2174\/157016210791330356","article-title":"Enhancing the delivery of anti retroviral drug \u201cSaquinavir\u201d across the blood brain barrier using nanoparticles","volume":"8","author":"Mahajan","year":"2010","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0275","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejpb.2009.11.001","article-title":"Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain","volume":"74","author":"Parikh","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejpb.2008.03.009","article-title":"Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles","volume":"70","author":"Wilson","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0285","first-page":"445","article-title":"Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles","volume":"6","author":"Tian","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0290","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/02652049809006836","article-title":"Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study","volume":"15","author":"Alyautdin","year":"1998","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0295","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1211\/0022357001774958","article-title":"Influence of nanoparticles on the brain-to-serum distribution and the metabolism of valproic acid in mice","volume":"52","author":"Darius","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0300","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2007.05.026","article-title":"Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration","volume":"121","author":"Gao","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1166\/jns.2009.007","article-title":"Solid lipid nanoparticles carrying oligonucleotides inhibit vascular endothelial growth factor expression in rat glioma models","volume":"1","author":"Brioschi","year":"2008","journal-title":"J. Nanoneurosci."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0310","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbalip.2010.02.007","article-title":"Formation and function of apolipoprotein E-containing lipoproteins in the nervous system","volume":"1801","author":"Vance","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0315","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/10611860600866872","article-title":"Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays","volume":"14","author":"De Juan","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0320","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/bm801026k","article-title":"Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood\u2013brain barrier","volume":"10","author":"Gil","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0325","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00018-007-6390-x","article-title":"Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells","volume":"64","author":"Kim","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(99)00063-2","article-title":"Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting","volume":"60","author":"Peracchia","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0335","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/bm060711a","article-title":"Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis","volume":"8","author":"Kim","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0340","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2009.03.002","article-title":"Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones","volume":"137","author":"Zensi","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0345","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0041-008X(83)90334-4","article-title":"Kinetic profile in blood and brain of the cholinesterase reactivating oxime HI-6 after intravenous administration to the rat","volume":"71","author":"Ligtenstein","year":"1983","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0350","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/10611860903105986","article-title":"Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries","volume":"17","author":"Hulsermann","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0355","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)35388-1","article-title":"Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood\u2013brain barrier in mouse","volume":"292","author":"Lee","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0360","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2009.04.035","article-title":"Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier","volume":"379","author":"Chang","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0773.1992.tb00512.x","article-title":"Recent developments in peptide drug delivery to the brain","volume":"71","author":"Pardridge","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0370","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0378-5173(90)90047-8","article-title":"Modification of the body distribution of poly(meth methacrylate)-nanoparticles in rats by coating with surfactants","volume":"61","author":"Tr\u00f6ster","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0375","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1124\/jpet.102.039669","article-title":"Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting","volume":"303","author":"Brigger","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0380","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/156720106776359230","article-title":"A review of nanocarrier-based CNS delivery systems","volume":"3","author":"Tiwari","year":"2006","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0385","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1461-5347(98)00117-5","article-title":"Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems","volume":"2","author":"Pardridge","year":"1999","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0390","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1023\/A:1010931127745","article-title":"Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery","volume":"18","author":"Calvo","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0395","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10611860290031868","article-title":"Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues","volume":"10","author":"Zara","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0400","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10611860290031877","article-title":"Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood\u2013brain barrier","volume":"10","author":"Kreuter","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0405","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1022604120952","article-title":"Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles","volume":"20","author":"Kreuter","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0410","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.105.097139","article-title":"Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain","volume":"317","author":"Michaelis","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0415","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10611860500071292","article-title":"Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns","volume":"13","author":"Goppert","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0420","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejpb.2008.05.007","article-title":"Delivery of nanoparticles to the brain detected by fluorescence microscopy","volume":"70","author":"Reimold","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0425","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10517-006-0456-x","article-title":"Effects of apolipoproteins on dalargin transport across the blood\u2013brain barrier","volume":"142","author":"Shamenkov","year":"2006","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0430","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/02652040600788080","article-title":"Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model","volume":"23","author":"Ambruosi","year":"2006","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0435","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1023\/A:1018942823676","article-title":"Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0440","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-3659(97)00061-8","article-title":"Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood\u2013brain barrier using surfactant-coated nanoparticles","volume":"49","author":"Kreuter","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0445","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2006.10.015","article-title":"Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants","volume":"117","author":"Petri","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0450","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2006.11.020","article-title":"Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood\u2013brain barrier","volume":"117","author":"Kratzer","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0455","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/1061186X.2010.513712","article-title":"Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood\u2013brain barrier and enter the rodent brain","volume":"18","author":"Zensi","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0460","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0465","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bit.21120","article-title":"Humanization of anti-human insulin receptor antibody for drug targeting across the human blood\u2013brain barrier","volume":"96","author":"Boado","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0470","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2008.08.021","article-title":"Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood\u2013brain barrier (BBB)","volume":"71","author":"Ulbrich","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0475","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611861003734001","article-title":"Targeting the insulin receptor: nanoparticles for drug delivery across the blood\u2013brain barrier (BBB)","volume":"19","author":"Ulbrich","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0480","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/bc050217o","article-title":"Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26","volume":"16","author":"Aktas","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0485","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10611860108997929","article-title":"Interaction of poly(butylcyanoacrylate) nanoparticles with the blood\u2013brain barrier in vivo and in vitro","volume":"9","author":"Alyaudtin","year":"2001","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0490","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.20048","article-title":"Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles","volume":"109","author":"Steiniger","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0495","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1166\/jns.2009.1003","article-title":"Increased numbers of injections of doxorubicin bound to nanoparticles lead to enhanced efficacy against rat glioblastoma 101\/8","volume":"1","author":"Wohlfart","year":"2009","journal-title":"J. Nanoneurosci."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0500","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5414\/NPP28153","article-title":"Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects","volume":"28","author":"Hekmatara","year":"2009","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0505","doi-asserted-by":"crossref","first-page":"e19121","DOI":"10.1371\/journal.pone.0019121","article-title":"Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers","volume":"6","author":"Wohlfart","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0510","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1215\/15228517-2007-062","article-title":"Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas","volume":"10","author":"Lamborn","year":"2008","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0515","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01842886","article-title":"Uptake of adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas","volume":"104","author":"von Holst","year":"1990","journal-title":"Acta Neurochir. (Wien)"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0520","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-4274(01)00456-8","article-title":"Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma","volume":"126","author":"Gelperina","year":"2002","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0525","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejpb.2009.09.003","article-title":"Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters","volume":"74","author":"Gelperina","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbamem.2005.11.010","article-title":"Lipid composition determines interaction of liposome membranes with Pluronic L61","volume":"1720","author":"Zhirnov","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2011.08.017_bb0535","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-2275(20)32028-9","article-title":"Apolipoprotein A-I: structure-function relationships","volume":"41","author":"Frank","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0540","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10611860500411043","article-title":"Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats","volume":"13","author":"Ambruosi","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0545","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10611860600636135","article-title":"Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats","volume":"14","author":"Ambruosi","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0550","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/bc100070g","article-title":"Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects","volume":"21","author":"Maeda","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0555","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1471-4159.1990.tb04886.x","article-title":"Capillary depletion method for quantification of blood\u2013brain barrier transport of circulating peptides and plasma proteins","volume":"54","author":"Triguero","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0560","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijpharm.2007.01.031","article-title":"Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity","volume":"337","author":"Pereverzeva","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0565","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxlet.2008.01.020","article-title":"Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats","volume":"178","author":"Pereverzeva","year":"2008","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0570","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10517-008-0065-y","article-title":"Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80","volume":"145","author":"Kurakhmaeva","year":"2008","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.jconrel.2011.08.017_bb0575","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911005852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911005852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T18:58:02Z","timestamp":1741460282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365911005852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0168365911005852"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.08.017","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}